Adjuvant Therapies
What are adjuvant therapies?
After surgical treatment of breast cancer, supplementary therapy is recommended in many cases. Adjuvant therapies are systemic or local treatments administered with the goal of reducing the risk of recurrence, eradicating any microscopic cancer cells that are undetectable by current examinations, and improving long-term prognosis.
The need for such treatment is not the same for all women. It depends on the stage of the disease, the biological characteristics of the tumor, and the individualized risk assessment. The final decision is always made in collaboration with the oncology team, through discussion and detailed counseling. Adjuvant therapy follows the surgical treatment of breast cancer and complements it, working to protect the long-term result that surgery achieves.
Chemotherapy
Chemotherapy is a systemic treatment that acts throughout the body and targets rapidly dividing cancer cells. It is not necessary in all cases of breast cancer. It is recommended primarily when there is an increased risk of recurrence, when the tumor displays aggressive biological characteristics, when it does not express hormone receptors, or when there is lymph node involvement.
Today, chemotherapy is significantly better tolerated compared to the past, as it is accompanied by organized supportive care that limits adverse effects and allows the woman to maintain her daily routine as much as possible.
Endocrine Therapy
When the tumor is positive for hormone receptors (ER/PR), endocrine therapy is a fundamental component of treatment. Its goal is to inhibit the action of estrogen on cancer cells, thereby significantly reducing the risk of recurrence. It is typically administered for a period of 5 to 10 years and has been proven to provide substantial benefit in long-term outcomes.
Targeted Therapies
In tumors with HER2 overexpression, specific monoclonal antibodies are used that precisely target this molecule. Targeted therapies have fundamentally changed the prognosis of HER2-positive tumors, significantly increasing survival rates and providing more personalized and effective treatment.
The biological characteristics that guide these choices — hormone receptor status, HER2 status, and the proliferation index — come directly from the pathology report of your biopsy and from analysis of the surgical specimen. This is why accurate tissue diagnosis is the foundation on which the entire adjuvant plan is built.
Radiation Therapy
Radiation therapy is a local treatment that targets the breast area and/or the axilla. It is recommended almost always after breast-conserving surgery (lumpectomy), while in selected cases it is also applied after mastectomy. Its purpose is to destroy any residual microscopic cancer cells, thereby reducing the risk of local recurrence.
Managing side effects
Every modality carries its own profile of possible side effects, and a central goal of modern care is to anticipate and minimize them. Chemotherapy may cause fatigue, hair loss, and a temporary drop in blood counts, all of which are managed with supportive medication and close monitoring. Endocrine therapy can bring menopausal-type symptoms such as hot flushes or joint stiffness, which often ease over time and can be addressed with simple measures. Radiation therapy is generally well tolerated, with skin redness in the treated area being the most common effect.
You are never expected to simply endure these effects in silence. Reporting symptoms early allows us to adjust doses, change supportive treatment, or alter the schedule so that the plan remains both effective and livable. Maintaining gentle physical activity, good nutrition, and emotional support throughout treatment makes a measurable difference to how you feel.
The decision is personalized
Not all women require all therapies. Modern oncology is based on molecular analysis of the tumor, precise estimation of individual risk, and close collaboration among different specialties within the tumor board.
The goal is not “maximum” treatment, but the right treatment — the one that offers the greatest benefit with the least possible burden.
Every treatment recommendation is tailored to the uniqueness of each woman, with respect for her body, her daily life, and her personal priorities.
For further reading on breast cancer treatment from an authoritative source, see the National Cancer Institute’s breast cancer resources.
Frequently Asked Questions
Will I definitely need chemotherapy after surgery?
No. Chemotherapy is not required for every breast cancer and many women never need it. The recommendation depends on the stage, the biological profile of the tumor, and modern genomic tests that estimate your individual risk of recurrence. Your oncology team will discuss whether the expected benefit justifies the treatment in your specific case.
How long does adjuvant treatment last?
It varies by modality. Chemotherapy is usually completed within a few months, radiation therapy over several weeks, while endocrine (hormone) therapy is taken as a daily tablet for 5 to 10 years. Targeted anti-HER2 treatment is typically given over about a year. Your personalized plan will set out the exact timeline in advance.
Are the side effects as severe as they used to be?
For most women, no. Supportive care has improved enormously, with effective medications to prevent nausea, protect blood counts, and manage fatigue. Many women continue working and caring for their families throughout treatment. We monitor you closely and adjust the plan whenever side effects affect your quality of life.
Can I make decisions about which treatments to accept?
Absolutely. Every recommendation is explained in full, including the benefits and the burdens, so that you can make an informed choice. Nothing is decided without you. Your values, your daily life, and your personal priorities are an essential part of the plan.